Smithfield Trust Co - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$50.0%1550.0%0.00%
Q2 2023$50.0%1550.0%0.00%
Q1 2023$5
-28.6%
1550.0%0.00%
Q4 2022$7
-99.9%
1550.0%0.00%
-100.0%
Q3 2022$8,000
+33.3%
1550.0%0.00%
Q2 2022$6,0000.0%1550.0%0.00%
Q1 2022$6,000
-14.3%
1550.0%0.00%
Q4 2021$7,000
+16.7%
1550.0%0.00%
Q3 2021$6,000
+100.0%
1550.0%0.00%
Q2 2021$3,000
-25.0%
1550.0%0.00%
Q1 2021$4,000
+33.3%
1550.0%0.00%
Q4 2020$3,0000.0%1550.0%0.00%
Q3 2020$3,0001550.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders